Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 dose-finding study of isupartob sodium in sepsis
TCTR20260209001Phase 2Not yet recruiting
- Sponsor
- Matisse Pharmaceuticals
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of isupartob sodium in sepsis, sponsored by Matisse Pharmaceuticals. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
isupartob sodium
03
Conditions
sepsis
Beyond the preview
Go deeper on TCTR20260209001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260209001.